Swiss - Delayed Quote CHF
Addex Therapeutics Ltd (ADXN.SW)
0.0504
-0.0028
(-5.26%)
As of 10:33:17 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | -0.01 | -0.03 | -0.07 | -0.06 |
Low Estimate | -0.01 | -0.03 | -0.07 | -0.07 |
High Estimate | -0.01 | -0.03 | -0.06 | -0.05 |
Year Ago EPS | -0.03 | -- | -0.14 | -0.07 |
Revenue Estimate
Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 3 |
Avg. Estimate | 150k | 200k | 1.5M | 766.67k |
Low Estimate | 150k | 200k | 1.5M | -- |
High Estimate | 150k | 200k | 1.5M | 1.5M |
Year Ago Sales | 153.45k | -- | 1.65M | 1.5M |
Sales Growth (year/est) | -2.25% | -- | -8.93% | -48.89% |
Earnings History
Currency in CHF | 12/31/2023 | 6/30/2024 | 9/30/2024 |
---|---|---|---|
EPS Est. | -0.03 | -0.01 | -0.01 |
EPS Actual | -0.03 | -0.01 | -0.02 |
Difference | 0 | 0 | -0.01 |
Surprise % | 0.00% | 0.00% | -100.00% |
EPS Trend
Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.01 | -0.03 | -0.07 | -0.06 |
7 Days Ago | -0.01 | -0.03 | -0.07 | -0.06 |
30 Days Ago | -0.01 | -0.03 | -0.07 | -0.06 |
60 Days Ago | -0.01 | 0 | -0.07 | -0.06 |
90 Days Ago | 0 | 0 | -0.07 | -0.06 |
EPS Revisions
Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ADXN.SW | 66.67% | -- | 52.69% | 7.55% |
S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Related Tickers
EVE.SW Evolva Holding SA
1.1000
0.00%
MOLN.SW Molecular Partners AG
3.4750
+2.51%
NWRN.SW Newron Pharmaceuticals S.p.A.
7.11
-2.60%
MNOV MediciNova, Inc.
1.4900
+0.68%
SANN.SW Santhera Pharmaceuticals Holding AG
14.30
-1.65%
TRDA Entrada Therapeutics, Inc.
8.73
+0.23%
IDIA.SW Idorsia Ltd
1.1340
-2.07%
22UA.F BioNTech SE
99.20
-1.78%
PEPG PepGen Inc.
1.5850
-1.55%
CLRB Cellectar Biosciences, Inc.
0.3113
-0.35%